Insiders · Profile

DiRaimondo Thomas

Chief Scientific Officer at Janux Therapeutics. Filing since 27 Sep 2024. CIK 0002005618

Company
Date
Role
Action
Shares
Amount
Of holding
2 Jan 2026
Chief Scientific Officer
Sold at will
2,505
$34.39K
2.0%
27 Sep 2024
Chief Scientific Officer
Sold on a plan
5,000
$231.72K
4.9%
2 decisions on file.